ctrl K

Immunome Inc. (IMNM)

NASDAQ: IMNM · Real-Time Price · USD

8.88

0.09 (1.02%)

At close: May 01, 2025, 3:59 PM

9.00

1.35%

Pre-market: May 02, 2025, 09:16 AM EDT

Immunome Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	9.04M	14.02M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	2.1M	22.93M	631K	755K	755K	615K	521K
Gross Profit	6.94M	-8.91M	-631K	-755K	-755K	-615K	-521K
Operating Income	-305.8M	-109.53M	-36.9M	-25.2M	-12.26M	-10.35M	-7.74M
Interest Income	12.84M	2.72M	5K	10K	1K	10K	39K
Pretax Income	-292.96M	-106.81M	-36.9M	-24.71M	-17.84M	-10.44M	-7.84M
Net Income	-292.96M	-106.81M	-37.51M	-24.47M	-17.12M	-10.55M	-7.84M
Selling & General & Admin	32.95M	19.66M	13.63M	11.09M	4.78M	1.52M	866K
Research & Development	152.34M	103.16M	23.27M	14.11M	7.49M	8.82M	6.88M
Other Expenses	129.54M	n/a	n/a	503K	n/a	n/a	n/a
Operating Expenses	314.84M	122.82M	36.9M	25.2M	12.26M	10.35M	7.74M
Interest Expense	n/a	n/a	5K	10K	38K	106K	141K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	314.84M	123.55M	36.9M	25.2M	12.26M	10.35M	7.74M
Income Tax Expense	n/a	n/a	617K	-242K	-717K	106K	39K
Shares Outstanding (Basic)	58.64M	19.84M	12.13M	11.54M	10.11M	5.74M	1.09M
Shares Outstanding (Diluted)	58.64M	19.84M	12.13M	11.54M	10.11M	5.74M	1.09M
EPS (Basic)	-5	-5.38	-3.09	-2.12	-1.69	-1.84	-7.18
EPS (Diluted)	-5	-5.38	-3.09	-2.12	-1.69	-1.84	-7.18
EBITDA	-151.35M	-28.27M	-36.27M	-23.95M	-17.04M	-9.72M	-7.18M
EBIT	-153.46M	-28.73M	-36.9M	-24.7M	-17.8M	-10.34M	-7.7M
Depreciation & Amortization	2.1M	728K	631K	755K	755K	615K	521K